Experience

Morse

• United States
• Law Practice
• 1 - 100 Employee

• Member

  • Jan 2022 - Present

  I am an experienced litigator and corporate counselor representing clients in state and federal court, at trial and on appeal. I have handled multiple jury trials, bench trials, and complex arbitrations. I regularly handle litigation, arbitration, and pre-litigation dispute resolution on matters related to mergers and acquisitions, employment, trade secret, product liability, securities, FCPA and widespread corporate governance matters. He has also represented numerous parties in interest and creditors in bankruptcy court. He represents businesses in a wide variety of industries, including biotech, pharmaceutical, health care, telecommunications, software, construction and real estate. Scott also has substantial experience performing internal investigations in response to requests from management, boards of directors, or government agencies concerning issues such as corporate governance, insider trading, and revenue recognition. Prior to law school, I was an organic chemist, and he brings that knowledge and experience to the work he does for clients in the biotech, health care and pharmaceutical industries. Show less

• Counsel

  • Oct 2019 - Dec 2021

  I am an experienced litigator and corporate counselor representing clients in state and federal court, at trial and on appeal. I have handled multiple jury trials, bench trials, and complex arbitrations. I regularly handle litigation, arbitration, and pre-litigation dispute resolution on matters related to mergers and acquisitions, employment, trade secret, product liability, securities, FCPA and widespread corporate governance matters. He has also represented numerous parties in interest and creditors in bankruptcy court. He represents businesses in a wide variety of industries, including biotech, pharmaceutical, health care, telecommunications, software, construction and real estate. Scott also has substantial experience performing internal investigations in response to requests from management, boards of directors, or government agencies concerning issues such as corporate governance, insider trading, and revenue recognition. Prior to law school, I was an organic chemist, and he brings that knowledge and experience to the work he does for clients in the biotech, health care and pharmaceutical industries. Show less



Locke Lord LLP

• United States
• Law Practice
• 700 & Above Employee

• Senior Counsel

  • Jan 2016 - Jul 2019

  Commercial litigator and counselor at the global law firm Locke Lord LLP. I focus my practice in several areas of business litigation and strategic advising, including cases arising out of mergers and acquisitions, construction disputes, governmental investigations, financial services, and general commercial disputes. I have represented clients in both state and federal court, both at the trial level and on appeal. Representative Litigation Matters: • Obtained a federal court jury verdict of $7.5 million in favor of a software manufacturer against reseller for breach of development and services contracts; defeated counterclaims seeking $23.5 million for alleged breach of fiduciary duty and breach of contract. • As lead counsel, successfully represented a manufacturer and installer of solar fields in a multimillion dollar arbitration brought against it by owner of solar field alleging claims of delay, defective design, and defective construction. • Successfully represented health care company in multiple state and federal court appeals by former company executives claiming rights under an asset purchase agreement after sale of a hospital in bankruptcy court. • Represented pharmaceutical companies asserting claims for breach of confidentiality agreement protecting trade secrets used in drug development process. Representative Investigations: • Represented publicly traded companies in internal investigations relating to FCPA concerns, alleged misstatement of financials, insider trading, and revenue recognition issues. Legal and strategic counseling to business units: • Regularly advise in house counsel, management and boards about legal risks and benefits related to business decisions. • Prepare and respond to pre-litigation demand letters arising out of business disputes. • Advise clients on negotiations concerning merger agreements, employment agreements, and other commercial agreements. Show less



EAPD Edwards Angell Palmer & Dodge LLP

• United States
• Law Practice
• 200 - 300 Employee

• Associate

  • Sep 2005 - Jul 2019

  Litigation associate, focusing in construction litigation, securities litigation, antitrust litigation, financial services litigation, and general commercial litigation. I am also active in the firm's pro bono efforts. Representative matters • Regularly advise in house counsel, management and boards about legal risks and benefits related to business decisions. • Conducted internal and external training concerning securities law, FCPA, and UK Bribery Act matters, among others. • Represented the acquirer in a post-closing indemnification dispute arising out of a stock purchase agreement at through trial and appeal. • Obtained summary judgment on behalf of a automobile finance company against claims of fraud and breach of contract brought in federal court by an automobile dealer. • Prepare and respond to pre-litigation demand letters arising out of business disputes. • Successfully defended numerous clients in shareholder class actions seeking to halt acquisitions or going private transactions. I was named a "Rising Star" by New England Super Lawyers Magazine for the the years 2010-2014 for the category of business litigation. Show less



Suntory Pharmaceutical Research Labs

• Associate Scientist

  • Mar 2001 - Aug 2002

  Designed and synthesized small molecule drug candidates as potential cardiovascular therapeutics; collaborated regularly with chemists, biochemists, molecular biologists, computational chemists, and pharmacologists in designing and testing drug candidates. Designed and synthesized small molecule drug candidates as potential cardiovascular therapeutics; collaborated regularly with chemists, biochemists, molecular biologists, computational chemists, and pharmacologists in designing and testing drug candidates.